Obtain Angel+ round investment

Selected as one of the key technical research projects for nucleic acid drugs by National Biopharmaceutical Technology Innovation Center

the Shanghai subsidiary certified as a technology-based small and medium-sized enterprise

Obtained Angel round investment

Company was established